Nektar Therapeutics — 재무제표 (NASDAQ:NKTR) | MetaTrader

전체 차트 열기

Financials

개요 성명 통계

총자산 1.54 B1.12 B710.6 M398.03 M303.85 M280.41 M 총 부채 461.47 M437.68 M343.96 M267.05 M243.11 M190.57 M 자본금 총액 1.08 B679.51 M366.64 M130.99 M60.74 M89.83 M 총 부채 및 주주자본 1.54 B1.12 B710.6 M398.03 M303.85 M280.41 M 총부채 —————— 순부채 ——————

뉴스

Nektar (NKTR) Moves 18.3% Higher: Will This Strength Last?

넥타 테라퓨틱스, 월요일 주가 18% 급등한 이유는?

Nektar Therapeutics (NKTR) Discusses 52-Week Topline Results From REZOLVE-AA Phase 2b Extension in Severe Alopecia Areata - Slideshow (NASDAQ:NKTR) 2026-04-20

Nektar Therapeutics (NKTR) Discusses 52-Week Topline Results From REZOLVE-AA Phase 2b Extension in Severe Alopecia Areata Transcript

Nektar Therapeutics Adds To Its 129% Two-Month Run With Alopecia News

Market Feels Weak, But Stocks Tell Stories

Stay Invested In U.S. Stocks, Don't Panic Sell, Also Buy Gold

넥타테라퓨틱스, TD Cowen ‘매수’ 의견 제시

Nektar Therapeutics stock initiated with buy rating at TD Cowen

Company News for Mar 16, 2026

오펜하이머, 넥타테라퓨틱스 목표 주가 $140로 상향

Oppenheimer raises Nektar Therapeutics price target to $140